Neuroscience Therapeutic Area Strategy

March 7, 2019 Leah Hoffmann

A VP at a major biopharma company was interested in defining his strategy in the neuroscience space. Looking for a more targeted way to assess the opportunity than big consulting firms could provide, he turned to BTG.

We deployed two ex-McKinsey life science strategists to develop a comprehensive therapeutic area strategy plan. Combining internal data with relevant secondary research, they worked with the client’s team to align around a defined set of priorities, establish target product profiles (TPPs) for each, and share with senior management.

Value: A comprehensive therapeutic area strategy with specific target product profiles

About the Author

Leah Hoffmann

Leah Hoffmann is a former journalist who has worked for Forbes.com and The Economist. She is passionate about clear thinking, sharp writing, and strong points of view.

More Content by Leah Hoffmann
Previous Article
The Strategic Planning Process: A Practical Guide
The Strategic Planning Process: A Practical Guide

There's often more focus on the strategic planning process than on actual strategic thought. Create more ef...

Next Flipbook
BTG Key Strengths: Market Landscape and Growth Analysis
BTG Key Strengths: Market Landscape and Growth Analysis

Conducting a market analysis doesn’t have to be complex or expensive. But it does have to be expertly done.

Get our free guide to working with on-demand talent.

Read Now